SREBF1 and ovarian carcinoma: Mechanistically, SREBP1 silencing promotes ubiquitination-mediated degradation of the Nrf2 protein, thereby suppressing the expression of XCT and GPX4, ultimately triggering ferroptosis in ovarian cancer cells.